These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19432812)

  • 21. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview on rodent models of Alzheimer's disease.
    Dodart JC; May P
    Curr Protoc Neurosci; 2005 Nov; Chapter 9():Unit 9.22. PubMed ID: 18428631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models of amyloid-beta-related pathologies in Alzheimer's disease.
    Philipson O; Lord A; Gumucio A; O'Callaghan P; Lannfelt L; Nilsson LN
    FEBS J; 2010 Mar; 277(6):1389-409. PubMed ID: 20136653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic fornix deep brain stimulation in a transgenic Alzheimer's rat model reduces amyloid burden, inflammation, and neuronal loss.
    Leplus A; Lauritzen I; Melon C; Kerkerian-Le Goff L; Fontaine D; Checler F
    Brain Struct Funct; 2019 Jan; 224(1):363-372. PubMed ID: 30341742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Alzheimer's mouse at last?
    Altman J
    Mol Med Today; 1995 Apr; 1(1):1. PubMed ID: 9415125
    [No Abstract]   [Full Text] [Related]  

  • 26. Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease.
    Willuweit A; Velden J; Godemann R; Manook A; Jetzek F; Tintrup H; Kauselmann G; Zevnik B; Henriksen G; Drzezga A; Pohlner J; Schoor M; Kemp JA; von der Kammer H
    PLoS One; 2009 Nov; 4(11):e7931. PubMed ID: 19936202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction.
    Fombonne J; Rabizadeh S; Banwait S; Mehlen P; Bredesen DE
    Ann Neurol; 2009 Mar; 65(3):294-303. PubMed ID: 19334058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preplaque ('preclinical') Aβ-induced inflammation and nerve growth factor deregulation in transgenic models of Alzheimer's disease-like amyloid pathology.
    Cuello AC; Ferretti MT; Iulita MF
    Neurodegener Dis; 2012; 10(1-4):104-7. PubMed ID: 22261363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and molecular biology of Alzheimer's disease and animal models.
    Price DL; Sisodia SS
    Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AβPP-overexpressing transgenic rat model of Alzheimer's disease utilizing the Tg2576 mouse protocol.
    O'Hare E; Ardis T; Page D; Scopes DI; Kim EM
    J Alzheimers Dis; 2013; 37(1):77-88. PubMed ID: 23780661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of beta-amyloid in Alzheimer's disease.
    Sinha S
    Med Clin North Am; 2002 May; 86(3):629-39. PubMed ID: 12168562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer's disease.
    Tag SH; Kim B; Bae J; Chang KA; Im HI
    Mol Brain; 2022 Jun; 15(1):51. PubMed ID: 35676711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the biology of Alzheimer's disease in mice.
    Ashe KH; Zahs KR
    Neuron; 2010 Jun; 66(5):631-45. PubMed ID: 20547123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic mouse models of Alzheimer's disease.
    Janus C; Chishti MA; Westaway D
    Biochim Biophys Acta; 2000 Jul; 1502(1):63-75. PubMed ID: 10899432
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of the Alzheimer's Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs.
    Jakobsen JE; Johansen MG; Schmidt M; Liu Y; Li R; Callesen H; Melnikova M; Habekost M; Matrone C; Bouter Y; Bayer TA; Nielsen AL; Duthie M; Fraser PE; Holm IE; Jørgensen AL
    J Alzheimers Dis; 2016 Jul; 53(4):1617-30. PubMed ID: 27540966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 'Alzheimer's mouse' produced.
    Marx J
    Science; 1996 Oct; 274(5285):177-8. PubMed ID: 8927978
    [No Abstract]   [Full Text] [Related]  

  • 37. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
    Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y
    PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selected mice models based on APP, MAPT and presenilin gene mutations in research on the pathogenesis of Alzheimer's disease].
    Więdłocha M; Stańczykiewicz B; Jakubik M; Rymaszewska J
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():415-30. PubMed ID: 22922141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel rat model of Alzheimer's disease based on lentiviral-mediated expression of mutant APP.
    Parsi S; Pandamooz S; Heidari S; Naji M; Morfini G; Ahmadiani A; Dargahi L
    Neuroscience; 2015 Jan; 284():99-106. PubMed ID: 25270904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Yang DS; Stavrides P; Mohan PS; Kaushik S; Kumar A; Ohno M; Schmidt SD; Wesson D; Bandyopadhyay U; Jiang Y; Pawlik M; Peterhoff CM; Yang AJ; Wilson DA; St George-Hyslop P; Westaway D; Mathews PM; Levy E; Cuervo AM; Nixon RA
    Brain; 2011 Jan; 134(Pt 1):258-77. PubMed ID: 21186265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.